☆ 4.6 Letter

Reversible dopamine transporter reduction in drug-induced parkinsonism

MOVEMENT DISORDERS (2014)

期刊

MOVEMENT DISORDERS

卷 29, 期 4, 页码 575-577

出版社

WILEY-BLACKWELL

DOI: 10.1002/mds.25828

关键词

-

类别

Clinical Neurology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Biochemistry & Molecular Biology

SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism

Gordana Nedic Erjavec, Mirko Grubor, Maja Zivkovic, Nada Bozina, Marina Sagud, Matea Nikolac Perkovic, Alma Mihaljevic-Peles, Nela Pivac, Dubravka Svob Strac

Summary: Antipsychotic-induced parkinsonism is the most common extrapyramidal side effect caused by the blockage of dopamine receptors. This study found significant associations between HTR6 gene polymorphism and tremor and rigidity induced by haloperidol. Additionally, a combined effect of HTR6 T and SLC6A3 9R alleles on AIP was observed.

BIOMEDICINES (2022)

添加到收藏夹

Article Psychiatry

Case Report: Bupropion Reduces the [123I]FP-CIT Binding to Striatal Dopamine Transporter

Ivan Milenkovic, Lucie Bartova, Konstantinos Papageorgiou, Siegfried Kasper, Tatjana Traub-Weidinger, Dietmar Winkler

Summary: Diagnosing parkinsonian syndromes in patients with severe depression can be challenging due to overlapping clinical phenomena. [I-123]FP-CIT-SPECT is a useful method for detecting degenerative parkinsonian disorders but drugs may influence the results. Consultation with a movement disorder specialist prior to dopamine transporter imaging is recommended.

FRONTIERS IN PSYCHIATRY (2021)

添加到收藏夹

Article Medicine, General & Internal

Retinal Thickness and Its Interocular Asymmetry Between Parkinson?s Disease and Drug-Induced Parkinsonism

Wool Suh, Sung Uk Baek, Jungsu S. Oh, Seung Yeon Seo, Jae Seung Kim, You Mie Han, Min Seung Kim, Suk Yun Kang

Summary: This study compared optical coherence tomography (OCT) findings and positron emission tomography findings between de novo Parkinson's disease (PD) patients and drug-induced parkinsonism (DIP) patients. The results showed that retinal thickness and interocular asymmetry measurements using OCT were not useful for distinguishing between PD and DIP in the early stages. Further investigations are needed for confirmation.

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

添加到收藏夹

Article Clinical Neurology

Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study

Kaki Tsang, Richard Walker

Summary: This study assessed the impact of DaT Scan imaging on the diagnosis and subsequent clinical management of patients with indeterminate Parkinsonism. The results showed that DaT scanning is useful for confirming the correct diagnosis and guiding the clinical management of Parkinsonism patients.

JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Small intestine neuromuscular dysfunction in a mouse model of dextran sulfate sodium-induced ileitis: Involvement of dopaminergic neurotransmission

Silvia Cerantola, Sofia Faggin, Valentina Caputi, Annalisa Bosi, Davide Banfi, Anna Rambaldo, Andrea Porzionato, Rosa Di Liddo, Raffaele De Caro, Edoardo Savarino, Cristina Giaroni, Maria Cecilia Giron

Summary: This study aims to evaluate the impact of ileitis on enteric dopaminergic pathways, and finds that ileitis mainly affects D1 receptor-mediated dopaminergic neurotransmission.

LIFE SCIENCES (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Identification of Critical Residues in the Carboxy Terminus of the Dopamine Transporter Involved in the G Protein βγ-Induced Dopamine Efflux

Jose A. Pino, Gabriel Nunez-Vivanco, Gabriela Hidalgo, Miguel Reyes Parada, Habibeh Khoshbouei, Gonzalo E. Torres

Summary: This study reveals that G protein beta gamma subunits can bind to the dopamine transporter (DAT) and activate DAT-mediated dopamine efflux, similar to the mechanism of action of psychostimulants like amphetamine (AMPH). Through a combination of computational biology, mutagenesis, biochemical, and functional assays, the amino acid residues within the 582-596 sequence of the DAT carboxy terminus involved in the DAT-G beta gamma interaction and G beta gamma-induced dopamine efflux were identified. Residues like R588 and F587 within the carboxy terminus of DAT play critical roles in the physical interaction between DAT and G beta gamma, influencing dopamine efflux.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism

Elena E. Vaiman, Natalia A. Shnayder, Aiperi K. Khasanova, Anna Strelnik, Arseny J. Gayduk, Mustafa Al-Zamil, Margarita R. Sapronova, Natalia G. Zhukova, Daria A. Smirnova, Regina F. Nasyrova

Summary: Drug-induced parkinsonism (DIP) is a common neurologic adverse reaction in patients with schizophrenia treated with antipsychotics. It is caused by drugs that affect dopamine receptors and disrupt the signaling pathways of various neurotransmitter systems. The mechanisms of DIP development are still poorly understood despite existing theories.

BIOMEDICINES (2022)

添加到收藏夹

Review Clinical Neurology

Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?

Stefano Calzetti, Anna Negrotti

Summary: Secondary parkinsonism induced by certain medications can be completely reversible in most patients after drug withdrawal, but in some cases it may become progressive or even permanent. Tardive parkinsonism, a controversial condition, may fulfill the criteria of permanent non-progressive parkinsonism and its long-term course and clinical features are not well understood.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

添加到收藏夹

Article Medicine, General & Internal

Treatment Changes and Prognoses in Patients with Incident Drug-Induced Parkinsonism Using a Korean Nationwide Healthcare Claims Database

Siin Kim, Hae Sun Suh

Summary: This retrospective cohort study analyzed treatment changes and prognoses of patients with incident drug-induced parkinsonism (DIP). Using a national database, patients diagnosed with DIP and prescribed offending drugs (antipsychotics, gastrointestinal motility drugs, or flunarizine) during 2004-2013 were assessed. The study found that treatment changes and prognoses varied based on the offending drug type, with over 25% of patients experiencing DIP recurrence or persistence, emphasizing the need for effective prevention strategies.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

D1, not D2, dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa

Richard B. Mailman, Yang Yang, Xuemei Huang

Summary: Research suggests that selective D-1 agonists may play a critical role in the treatment of Parkinson's disease, providing profound symptomatic relief even when current drugs are ineffective. Existing Parkinson's medications have limited efficacy in severe cases, but high intrinsic activity D-1 agonists could offer a major therapeutic advance in improving patients' quality of life.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

添加到收藏夹

Article Cell Biology

Loss-of-Function Variants in DRD1 in Infantile Parkinsonism-Dystonia

Kimberley Reid, Dora Steel, Sanjana Nair, Sanjay Bhate, Lorenzo Biassoni, Sniya Sudhakar, Michelle Heys, Elizabeth Burke, Erik-Jan Kamsteeg, Biju E. Hameed, Michael Zech, Niccolo Mencacci, Katy A. Barwick, Maya Topf, Manju Kurian

Summary: In this study, a patient with severe infantile parkinsonism-dystonia was reported, exhibiting clinical features of dopamine deficiency. Whole-genome sequencing identified a homozygous variant in the DRD1 gene, resulting in loss of function of the D-1 receptor. The findings highlight the crucial role of the D-1 receptor in motor control.

CELLS (2023)

添加到收藏夹

Article Clinical Neurology

The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism

Yang Hyun Lee, Sangwon Lee, Seok Jong Chung, Han Soo Yoo, Jin Ho Jung, Kyoungwon Baik, Byoung Seok Ye, Young H. Sohn, Mijin Yun, Phil Hyu Lee

Summary: This study demonstrates that VaP patients with WMH exhibit diffusely decreased DAT availability without any specific regional gradients of DAT patterns distinct from either control subjects or PD patients.

PARKINSONISM & RELATED DISORDERS (2021)

添加到收藏夹

Article Biophysics

Doxorubicin induced aggregation of ?-synuclein: Insights into the mechanism of drug induced Parkinsonism

Ankush Garg, Sharmistha Sinha

Summary: The aggregation of alpha-synuclein is a key characteristic of Parkinson's disease and is influenced by the chemotherapeutic drug doxorubicin. The study reveals that doxorubicin interacts with the aggregation-prone region of alpha-synuclein, destabilizing it and promoting aggregation. Additionally, the combination of doxorubicin and L-DOPA drugs inhibits alpha-synuclein aggregation.

COLLOIDS AND SURFACES B-BIOINTERFACES (2022)

添加到收藏夹

Article Medicine, General & Internal

Trial of Deferiprone in Parkinson's Disease

David Devos, Julien Labreuche, Olivier Rascol, Jean-Christophe Corvol, Alain Duhamel, P. Guyon Delannoy, Werner Poewe, Yaroslau Compta, Nicola Pavese, Evzen Ruzicka, Petr Dusek, Bart Post, Bastiaan R. Bloem, Daniela Berg, Walter Maetzler, Markus Otto, Marie-Odile Habert, Stephane Lehericy, Joaquim Ferreira, Richard Dodel, Christine Tranchant, Alexandre Eusebio, Stephane Thobois, Ana-Raquel Marques, Wassilios G. Meissner, Fabienne Ory-Magne, Uwe Walter, Rob M. A. de Bie, Miguel Gago, Dolores Vilas, Jaime Kulisevsky, Cristina Januario, Miguel V. S. Coelho, Stefanie Behnke, Paul Worth, Klaus Seppi, Thavarak Ouk, Camille Potey, Celine Leclercq, Romain Viard, Gregory Kuchcinski, Renaud Lopes, Jean-Pierre Pruvo, Pascal Pigny, Guillaume Garcon, Ophelie Simonin, Jessica Carpentier, Anne-Sophie Rolland, Dag Nyholm, Christoph Scherfler, Jean-Francois Mangin, Marie Chupin, Regis Bordet, David T. Dexter, Caroline Fradette, Michael Spino, Fernando Tricta, Scott Ayton, Ashley I. Bush, Jean-Christophe Devedjian, James A. Duce, Ioav Cabantchik, Luc Defebvre, Dominique Deplanque, Caroline Moreau

Summary: In a 36-week trial involving participants with early Parkinson's disease who had not received levodopa, treatment with the iron chelator deferiprone led to worse scores in measures of parkinsonism compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Geriatrics & Gerontology

Aging-Related Catatonia with Reversible Dopamine Transporter Dysfunction in Females with Depressive Symptoms: A Case Series

Kaoru Arai, Hitoshi Sakimoto, Yuka Urata, Mai Kariya, Takeshi Nakamura, Tatsuki Ikehata, Rion Shimojima, Naomi Furue, Takanori Ishizuka, Akira Sano, Masayuki Nakamura

Summary: This study describes five depressive patients with initially decreased striatal accumulation of dopamine transporter (DAT) single-photon emission computed tomography (SPECT), which improved along with clinical symptoms. Two of the patients were initially diagnosed with probable dementia with Lewy bodies (DLB), but no longer met the diagnostic criteria after symptom improvement.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2023)

添加到收藏夹

Article Neurosciences

Resting energy expenditure in Parkinson's disease patients under dopaminergic treatment

Michela Barichella, Emanuele Cereda, Samanta Andrea Faierman, Gabriele Piuri, Carlotta Bolliri, Valentina Ferri, Erica Cassani, Eleonora Vaccarella, Ornella Violetta Donnarumma, Giovanna Pinelli, Serena Caronni, Chiara Pusani, Gianni Pezzoli

Summary: By conducting a case-control study, we found that Parkinson's disease (PD) patients do not commonly have an increase in resting energy expenditure (REE), but it does increase in patients with obesity and more severe disease. The accuracy of existing REE equations is limited, while the new equation we proposed in this study provides better REE estimates.

NUTRITIONAL NEUROSCIENCE (2022)

添加到收藏夹

Article Neurosciences

Astrocytes expressing Vitamin D-activating enzyme identify Parkinson's disease

Samanta Mazzetti, Michela Barichella, Federica Giampietro, Angelica Giana, Alessandra M. Calogero, Alida Amadeo, Nicola Palazzi, Alessandro Comincini, Giorgio Giaccone, Manuela Bramerio, Serena Caronni, Viviana Cereda, Emanuele Cereda, Graziella Cappelletti, Chiara Rolando, Gianni Pezzoli

Summary: This study found a specific subpopulation of astrocytes in the brains of Parkinson's disease (PD) patients, which can protect neurons by sequestering alpha-Synuclein oligomers and are associated with Lewy body negative neurons. These findings suggest the potential neuroprotective role of the vitamin D pathway in neurodegenerative diseases.

CNS NEUROSCIENCE & THERAPEUTICS (2022)

添加到收藏夹

Article Geriatrics & Gerontology

The Hopkins Symptom Checklist (SCL-90-R): A Patient-Reported Outcome Measure in Parkinson's Disease

Danilo Carrozzino, Kaj Sparle Christensen, Chiara Patierno, Chiara Siri, Anna Zecchinelli, Gianni Pezzoli, Fiammetta Cosci

Summary: The study applied CLIPROM criteria to evaluate the validity, sensitivity, and utility of SCL-90-R in PD patients, finding the total score to be sensitive for screening and recommending the use of brief versions of subscales without misfitting items for assessing specific symptoms.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study

Cloe Domenighetti, Pierre-Emmanuel Sugier, Ashwin Ashok Kumar Sreelatha, Claudia Schulte, Sandeep Grover, Oceane Mohamed, Berta Portugal, Patrick May, Dheeraj R. Bobbili, Milena Radivojkov-Blagojevic, Peter Lichtner, Andrew B. Singleton, Dena G. Hernandez, Connor Edsall, George D. Mellick, Alexander Zimprich, Walter Pirker, Ekaterina Rogaeva, Anthony E. Lang, Sulev Koks, Pille Taba, Suzanne Lesage, Alexis Brice, Jean-Christophe Corvol, Marie-Christine Chartier-Harlin, Eugenie Mutez, Kathrin Brockmann, Angela B. Deutschlaender, Georges M. Hadjigeorgiou, Efthimos Dardiotis, Leonidas Stefanis, Athina Maria Simitsi, Enza Maria Valente, Simona Petrucci, Stefano Duga, Letizia Straniero, Anna Zecchinelli, Gianni Pezzoli, Laura Brighina, Carlo Ferrarese, Grazia Annesi, Andrea Quattrone, Monica Gagliardi, Hirotaka Matsuo, Yusuke Kawamura, Nobutaka Hattori, Kenya Nishioka, Sun Ju Chung, Yun Joong Kim, Pierre Kolber, Bart P. C. van de Warrenburg, Bastiaan R. Bloem, Jan Aasly, Mathias Toft, Lasse Pihlstrom, Leonor Correia Guedes, Joaquim J. Ferreira, Soraya Bardien, Jonathan Carr, Eduardo Tolosa, Mario Ezquerra, Pau Pastor, Monica Diez-Fairen, Karin Wirdefeldt, Nancy L. Pedersen, Caroline Ran, Andrea C. Belin, Andreas Puschmann, Clara Hellberg, Carl E. Clarke, Karen E. Morrison, Manuela Tan, Dimitri Krainc, Lena F. Burbulla, Matt J. Farrer, Rejko Kruger, Thomas Gasser, Manu Sharma, Alexis Elbaz

Summary: There is an association between genetically predicted dairy intake and Parkinson's disease, particularly in men. This causal relationship is not explained by reverse causation or confounding factors, as confirmed by Mendelian randomization analysis.

MOVEMENT DISORDERS (2022)

添加到收藏夹

Letter Clinical Neurology

VPS13C-associated Parkinson's disease: Two novel cases and review of the literature

Edoardo Monfrini, Francesca Spagnolo, Margherita Canesi, Agostino Seresini, Augusto Rini, Bruno Passarella, Marco Percetti, Manuela Seia, Stefano Goldwurm, Viviana Cereda, Giacomo P. Comi, Gianni Pezzoli, Alessio Di Fonzo

Summary: VPS13C mutations are associated with early-onset Parkinson's disease and dementia with Lewy bodies. Neuropathological studies on two mutated subjects showed diffuse Lewy body disease.

PARKINSONISM & RELATED DISORDERS (2022)

添加到收藏夹

Article Neurosciences

Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease

Cloe Domenighetti, Pierre-Emmanuel Sugier, Ashwin Ashok Kumar Sreelatha, Claudia Schulte, Sandeep Grover, Oceane Mohamed, Berta Portugal, Patrick May, Dheeraj R. Bobbili, Milena Radivojkov-Blagojevic, Peter Lichtner, Andrew B. Singleton, Dena G. Hernandez, Connor Edsall, George D. Mellick, Alexander Zimprich, Walter Pirker, Ekaterina Rogaeva, Anthony E. Lang, Sulev Koks, Pille Taba, Suzanne Lesage, Alexis Brice, Jean-Christophe Corvol, Marie-Christine Chartier-Harlin, Eugenie Mutez, Kathrin Brockmann, Angela B. Deutschlaender, Georges M. Hadjigeorgiou, Efthimos Dardiotis, Leonidas Stefanis, Athina Maria Simitsi, Enza Maria Valente, Simona Petrucci, Stefano Duga, Letizia Straniero, Anna Zecchinelli, Gianni Pezzoli, Laura Brighina, Carlo Ferrarese, Grazia Annesi, Andrea Quattrone, Monica Gagliardi, Hirotaka Matsuo, Yusuke Kawamura, Nobutaka Hattori, Kenya Nishioka, Sun Ju Chung, Yun Joong Kim, Pierre Kolber, Bart Pc van de Warrenburg, Bastiaan R. Bloem, Jan Aasly, Mathias Toft, Lasse Pihlstrom, Leonor Correia Guedes, Joaquim J. Ferreira, Soraya Bardien, Jonathan Carr, Eduardo Tolosa, Mario Ezquerra, Pau Pastor, Monica Diez-Fairen, Karin Wirdefeldt, Nancy L. Pedersen, Caroline Ran, Andrea C. Belin, Andreas Puschmann, Clara Hellberg, Carl E. Clarke, Karen E. Morrison, Manuela Tan, Dimitri Krainc, Lena F. Burbulla, Matt J. Farrer, Rejko Krueger, Thomas Gasser, Manu Sharma, Alexis Elbaz

Summary: This study used a two-sample Mendelian randomization method to analyze the associations of smoking, alcohol drinking, and coffee drinking with Parkinson's disease (PD). The results showed that smoking was inversely associated with PD, while genetic liability was positively associated with PD. The associations of alcohol drinking and coffee drinking with PD were limited by insufficient statistical power.

JOURNAL OF PARKINSONS DISEASE (2022)

添加到收藏夹

Article Clinical Neurology

Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors

Hui Liu, Mohammad Dehestani, Cornelis Blauwendraat, Mary B. Makarious, Hampton Leonard, Jonggeol J. Kim, Claudia Schulte, Alastair Noyce, Benjamin M. Jacobs, Isabelle Foote, Manu Sharma, Mike Nalls, Andrew Singleton, Thomas Gasser, Sara Bandres-Ciga

Summary: This study aims to understand why some individuals with high genetic risk do not develop Parkinson's disease (PD). Using large datasets of genetic data, the study found that a higher genetic resilience score was associated with a lower risk for PD. The study also identified potential genes and pathways related to resilience against PD.

ANNALS OF NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk

Letizia Straniero, Valeria Rimoldi, Edoardo Monfrini, Salvatore Bonvegna, Giada Melistaccio, Julie Lake, Giulia Solda, Massimo Aureli, Shankaracharya, Pamela Keagle, Tatiana Foroud, John E. Landers, Cornelis Blauwendraat, Anna Zecchinelli, Roberto Cilia, Alessio Di Fonzo, Gianni Pezzoli, Stefano Duga, Rosanna Asselta

Summary: The study evaluated the contribution of rare variants in genes responsible for lysosomal storage disorders (LSDs) to the risk of Parkinson's disease (PD) associated with the GBA gene. It found a significantly increased burden of deleterious variants in LSD genes in PD patients and identified the second variation in GBA and variants in genes causing mucopolysaccharidoses as the strongest modifiers of GBA penetrance.

MOVEMENT DISORDERS (2022)

添加到收藏夹

Article Clinical Neurology

Gut Microbiota in Monozygotic Twins Discordant for Parkinson's Disease

Carlotta Bolliri, Alessandra Fontana, Emanuele Cereda, Michela Barichella, Roberto Cilia, Valentina Ferri, Serena Caronni, Daniela Calandrella, Lorenzo Morelli, Gianni Pezzoli

Summary: Differences in gut microbiota between Parkinson's disease patients and controls may be influenced by various confounding factors. Using monozygotic twins, this study controlled for these factors and found minimal differences in bacterial taxa abundance and predicted metabolic pathways. Further research is needed to understand the role of gut microbiota in the pathogenesis of Parkinson's disease.

ANNALS OF NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusion

Federica Garri, Francesco Paolo Russo, Tommaso Carrer, Luca Weis, Francesca Pistonesi, Michele Mainardi, Michele Sandre, Edoardo Savarino, Fabio Farinati, Francesca Del Sorbo, Paola Soliveri, Daniela Calandrella, Roberta Biundo, Miryam Carecchio, Anna Lena Zecchinelli, Gianni Pezzoli, Angelo Antonini

Summary: This study retrospectively analyzed the usage of LCIG in 79 patients with Parkinson's disease and found that it has a relatively satisfactory long-term safety profile and efficacy, with a low rate of discontinuation. Peristomal complications may be a predictor of longer duration of therapy.

JOURNAL OF NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited

Cloe Domenighetti, Venceslas Douillard, Pierre-Emmanuel Sugier, Ashwin Ashok Kumar Sreelatha, Claudia Schulte, Sandeep Grover, Patrick May, Dheeraj R. Bobbili, Milena Radivojkov-Blagojevic, Peter Lichtner, Andrew B. Singleton, Dena G. Hernandez, Connor Edsall, Pierre-Antoine Gourraud, George D. Mellick, Alexander Zimprich, Walter Pirker, Ekaterina Rogaeva, Anthony E. Lang, Sulev Koks, Pille Taba, Suzanne Lesage, Alexis Brice, Jean-Christophe Corvol, Marie-Christine Chartier-Harlin, Eugenie Mutez, Kathrin Brockmann, Angela B. Deutschlander, Georges M. Hadjigeorgiou, Efthimos Dardiotis, Leonidas Stefanis, Athina Maria Simitsi, Enza Maria Valente, Simona Petrucci, Stefano Duga, Letizia Straniero, Anna Zecchinelli, Gianni Pezzoli, Laura Brighina, Carlo Ferrarese, Grazia Annesi, Andrea Quattrone, Monica Gagliardi, Hirotaka Matsuo, Akiyoshi Nakayama, Nobutaka Hattori, Kenya Nishioka, Sun Ju Chung, Yun Joong Kim, Pierre Kolber, Bart P. C. van de Warrenburg, Bastiaan R. Bloem, Jan Aasly, Mathias Toft, Lasse Pihlstrom, Leonor Correia Guedes, Joaquim J. Ferreira, Soraya Bardien, Jonathan Carr, Eduardo Tolosa, Mario Ezquerra, Pau Pastor, Monica Diez-Fairen, Karin Wirdefeldt, Nancy L. Pedersen, Caroline Ran, Andrea C. Belin, Andreas Puschmann, Emil Ygland Rodstrom, Carl E. Clarke, Karen E. Morrison, Manuela Tan, Dimitri KraincMD, Lena F. Burbulla, Matt J. Farrer, Rejko Kruger, Thomas Gasser, Manu Sharma, Nicolas Vince, Alexis Elbaz

Summary: This study conducted a large-scale independent replication of the interaction between HLA-DRB1 and smoking in Parkinson's disease. The valine at position 11 (V11) in HLA-DRB1 showed the strongest association with PD at the amino acid level. The results suggest an inverse association between genetically predicted smoking initiation and PD, particularly in individuals without the V11 variant. In silico predictions support this interaction pattern by showing the influence of V11 and smoking-induced modifications on binding affinity of alpha-synuclein.

MOVEMENT DISORDERS (2022)

添加到收藏夹

Review Neurosciences

Vitamin D Status and Parkinson's Disease

Michela Barichella, Federica Garri, Serena Caronni, Carlotta Bolliri, Luciano Zocchi, Maria Carmela Macchione, Valentina Ferri, Daniela Calandrella, Gianni Pezzoli

Summary: Parkinson's disease is a neurodegenerative disorder characterized by motor symptoms and various non-motor symptoms. Recent research has suggested a potential correlation between vitamin D and Parkinson's disease, although the mechanisms and efficacy are still unclear.

BRAIN SCIENCES (2022)

添加到收藏夹

Review Neurosciences

Precision Medicine in Parkinson's Disease: From Genetic Risk Signals to Personalized Therapy

Giulia Straccia, Fabiana Colucci, Roberto Eleopra, Roberto Cilia

Summary: Understanding the pathophysiology and genetic background of Parkinson's disease is crucial for developing effective disease-modifying therapeutic strategies. The discovery of genetic variants causing or increasing the risk for PD has contributed to refining the classification of the disease and guiding the decision-making process on different therapies. However, the heterogeneity in molecular pathophysiology among PD populations may explain the disappointing results of current disease-modifying strategies. Personalized medicine should be prioritized in the future. This review discusses the current therapeutic options for PD and the challenges in successful clinical trials, as well as the role of genetics in guiding treatment decisions in daily clinical practice.

BRAIN SCIENCES (2022)

添加到收藏夹

Article Neurosciences

Clinical correlates of serum 25-hydroxyvitamin D in Parkinson's disease

Michela Barichella, Emanuele Cereda, Laura Iorio, Giovanna Pinelli, Valentina Ferri, Erica Cassani, Carlotta Bolliri, Serena Caronni, Chiara Pusani, Maria Giulia Schiaffino, Angelica Giana, Elena Quacci, Caterina Esposito, Francesca Monti Guarnieri, Aurora Colombo, Francesca Del Sorbo, Roberto Cilia, Giorgio Sacilotto, Giulio Riboldazzi, Anna Lena Zecchinelli, Gianni Pezzoli

Summary: This study found that Parkinson's disease patients have lower levels of serum 25-hydroxyvitamin D than the general population, and low levels of serum 25-hydroxyvitamin D are associated with more severe disease, worse symptoms, and greater impairment of global cognitive function.

NUTRITIONAL NEUROSCIENCE (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.